مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Effects of microplasmin on recovery in a rat embolic stroke model.
Normal view MARC view ISBD view

Effects of microplasmin on recovery in a rat embolic stroke model. [electronic resource]

By:
  • Rasmussen, Rune Skovgaard
Contributor(s):
  • Overgaard, Karsten
  • Pakola, Steve
  • Boysen, Gudrun
Producer: 20080620Description: 75-81 p. digitalISSN:
  • 0161-6412
Subject(s):
  • Angiography -- methods
  • Animals
  • Behavior, Animal -- drug effects
  • Body Weight -- drug effects
  • Brain Infarction -- etiology
  • Disease Models, Animal
  • Eating -- drug effects
  • Fibrinolysin -- therapeutic use
  • Fibrinolytic Agents -- therapeutic use
  • Infarction, Middle Cerebral Artery -- drug therapy
  • Male
  • Motor Activity -- drug effects
  • Neurologic Examination
  • Peptide Fragments -- therapeutic use
  • Rats
  • Rats, Sprague-Dawley
  • Recovery of Function -- drug effects
  • Statistics, Nonparametric
  • Thrombolytic Therapy -- methods
  • Time Factors
Online resources:
  • Available from publisher's website
In: Neurological research vol. 30
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 41 [Thrombocytopenia and thrombocytopathy in neonates and infants].
    by Brolíková, D
  • 42 [Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].
    by Prikryl, P
  • 43 [Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia].
    by Penka, M
  • 44 [Significance of urokinase and its inhibitors in the invasiveness and metastasing of malignant tumors].
    by Halámková, J
  • 45 Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
    by Blatny, J
  • 46 Efficacy and safety of chronic hepatitis C treatment in hemophilic patients.
    by Husa, P
  • 47 [Preparation of patients on anticoagulant treatment for invasive surgery].
    by Brejcha, M
  • 48 Hemocoagulation disorders in extensively burned patients: pilot study for scoring of the DIC.
    by Lipový, B
  • 49 High Level of Circulating Microparticles in Patients with BCR/ABL Negative Myeloproliferative Neoplasm - a Pilot Study.
    by Aswad, M H
  • 50 Herpes simplex infection as possible etiology for febrile neutropenia and mucositis in patients treated for hematological malignancies.
    by Kubesová, H
  • 51 Sample processing and methodological pitfalls in multiple myeloma research.
    by Potácová, A
  • 52 [Warning signs preceding the development of septic shock in patients with neutropenia treated for hematologic malignancies].
    by Kubesová, H
  • 53 [Involvement of the cardiac muscle in anemia].
    by Elbl, L
  • 54 Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
    by Salaj, P
  • 55 [The effectiveness of anagrelide treatment in patients with Ph negative myeloproliferative diseases: influence on the incidence of thrombosis in the data from the Registry of patients with essential thrombocythemia and thrombocythemia associated with other myeloproliferative diseases treated with Thromboreductin® to the end of 2012].
    by Penka, M
  • 56 Minimal Residual Disease Assessment in Multiple Myeloma by Multiparametric Flow Cytometry.
    by Rihova, L
  • 57 [The preparation of a patient with long-term anticoagulant cumarin treatment for invasive surgery].
    by Penka, M
  • 58 Severe postpartum haemorrhage treated with recombinant activated factor VII in 80 Czech patients: analysis of the UniSeven registry.
    by Blatný, J
  • 59 Biobanking - the First Step to Successful Liquid Biopsy Experiments.
    by Almasi, M
  • 60 Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy.
    by Ocadlikova, Darina
Close

Effects of microplasmin on recovery in a rat embolic stroke model.

APA

Rasmussen R. S., Overgaard K., Pakola S. & Boysen G. (20080620). Effects of microplasmin on recovery in a rat embolic stroke model. : Neurological research.

Chicago

Rasmussen Rune Skovgaard, Overgaard Karsten, Pakola Steve and Boysen Gudrun. 20080620. Effects of microplasmin on recovery in a rat embolic stroke model. : Neurological research.

Harvard

Rasmussen R. S., Overgaard K., Pakola S. and Boysen G. (20080620). Effects of microplasmin on recovery in a rat embolic stroke model. : Neurological research.

MLA

Rasmussen Rune Skovgaard, Overgaard Karsten, Pakola Steve and Boysen Gudrun. Effects of microplasmin on recovery in a rat embolic stroke model. : Neurological research. 20080620.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site